Abstract:Transforming growth factor-β (TGF-β) inhibits the proliferation of epithelial cells by altering the expression or function of various components of the cell cycle machinery. Expression of one of these components, cyclin A, is inhibited by TGF-β treatment. We have identified a 760-base pair fragment of the human cyclin A gene promoter that is sufficient to confer TGF-β responsiveness. Using this promoter fragment, we have developed a cyclin A-based luciferase reporter assay that quantitates the growth inhibitory effect of TGF-β in transient transfection assays. This assay was used to determine which domains of the type I (RI) and type II (RII) receptors were required for the antiproliferative effect of TGF-β. In parallel, the functionality of chimeric receptors, between RI and RII (RI-RII or RII-RI), was tested for TGF-β effect on gene expression using a reporter assay based on the plasminogen activator inhibitor type 1 (PAI-1) promoter. We found that TGF-β-induced inhibition of cyclin A expression was absent in RI or RII-deficient Mv1Lu cells and that this response was restored by expression of wild-type type I or type II receptors in these cells. Furthermore, expression of a single chimeric receptor, either RI-RII or RII-RI, did not confer cyclin A regulation by TGF-β. However, expression of two reciprocal chimeras (RI-RII and RII-RI) resulted in growth inhibition, similarly to wild-type receptors. In addition, chimeric receptors as well as mutant receptors with a deleted cytoplasmic domain and kinase-negative receptors inhibited TGF-β responsiveness in the cyclin A reporter assay in a dominant negative fashion. Finally, in both receptor types, the juxtamembrane domain preceding the kinase domain was essential for receptor function but the cytoplasmic tail was dispensable. Our results suggest that a functional TGF-β receptor complex is required for TGF-β-dependent down-regulation of cyclin A gene expression and illustrate the identical receptor requirements for TGF-β-induced growth inhibition and gene expression. Transforming growth factor-β (TGF-β) inhibits the proliferation of epithelial cells by altering the expression or function of various components of the cell cycle machinery. Expression of one of these components, cyclin A, is inhibited by TGF-β treatment. We have identified a 760-base pair fragment of the human cyclin A gene promoter that is sufficient to confer TGF-β responsiveness. Using this promoter fragment, we have developed a cyclin A-based luciferase reporter assay that quantitates the growth inhibitory effect of TGF-β in transient transfection assays. This assay was used to determine which domains of the type I (RI) and type II (RII) receptors were required for the antiproliferative effect of TGF-β. In parallel, the functionality of chimeric receptors, between RI and RII (RI-RII or RII-RI), was tested for TGF-β effect on gene expression using a reporter assay based on the plasminogen activator inhibitor type 1 (PAI-1) promoter. We found that TGF-β-induced inhibition of cyclin A expression was absent in RI or RII-deficient Mv1Lu cells and that this response was restored by expression of wild-type type I or type II receptors in these cells. Furthermore, expression of a single chimeric receptor, either RI-RII or RII-RI, did not confer cyclin A regulation by TGF-β. However, expression of two reciprocal chimeras (RI-RII and RII-RI) resulted in growth inhibition, similarly to wild-type receptors. In addition, chimeric receptors as well as mutant receptors with a deleted cytoplasmic domain and kinase-negative receptors inhibited TGF-β responsiveness in the cyclin A reporter assay in a dominant negative fashion. Finally, in both receptor types, the juxtamembrane domain preceding the kinase domain was essential for receptor function but the cytoplasmic tail was dispensable. Our results suggest that a functional TGF-β receptor complex is required for TGF-β-dependent down-regulation of cyclin A gene expression and illustrate the identical receptor requirements for TGF-β-induced growth inhibition and gene expression.

Requirement of Transforming Growth Factor-β (Tgf-Β) Type II Receptor for TGF-β-induced Proliferation and Growth Inhibition (*)

Mechanisms of TGFβ Inhibition of LUNG Endodermal Morphogenesis: the Role of TβRII, Smads, Nkx2.1 and Pten

Tgf-Beta 1 Induced Fibroblast Proliferation is Mediated by the Fgf-2/Erk Pathway

Transforming Growth Factor-β (TGF-β)-induced Down-regulation of Cyclin A Expression Requires a Functional TGF-β Receptor Complex

[Transforming Growth Factor-Beta1 Induced Phenotypic Differentiation of Human Lung Fibroblasts Through Mitogen Activated Protein Kinase-Dependent Pathway].

Transforming growth factor (TGF-beta)-specific signaling by chimeric TGF-beta type II receptor with intracellular domain of activin type IIB receptor.

TGF2 and TGF3 isoforms drive fibrotic disease pathogenesis

Transforming growth factor-beta receptor type 1 (TGFbetaRI) kinase activity but not p38 activation is required for TGFbetaRI-induced myofibroblast differentiation and profibrotic gene expression.

Transforming growth factor type beta: rapid induction of fibrosis and angiogenesis in vivo and stimulation of collagen formation in vitro.

Regulation of Fibroblastic and Epithelial Cell Function by Transforming Growth Factors

Distinct Transforming Growth Factor-Beta (Tgf-Beta) Receptor Subsets As Determinants of Cellular Responsiveness to Three TGF-beta Isoforms.

TGF-beta regulates differentially the proliferation of fetal and adult human skin fibroblasts via the activation of PKA and the autocrine action of FGF-2

Concerted Action of TGF-beta 1 and Its Type II Receptor in Control of Epidermal Homeostasis in Transgenic Mice.

Transforming Growth Factor-β1 Stimulates the Proliferation of Rat Lung Fibroblasts in vitro

Epithelium-specific Deletion of TGF-β Receptor Type II Protects Mice from Bleomycin-Induced Pulmonary Fibrosis.

Transforming Growth Factor Β Signal Transduction

TGF-β Signaling in Lung Health and Disease

Blocking transforming growth factor-β signaling decreases dermal fibroblast proliferation and typeⅠcollagen production

Transforming growth factor-β1 small interfering RNA inhibits growth of human embryonic lung fibroblast HFL-I cells in vitro and defends against radiation-induced lung injury in vivo.

Transforming Growth Factor: Signal Transduction Pathways, Cell Cycle Mediation, And Effects On Hematopoiesis

Transforming growth factor-beta 1 (TGF-beta 1) and recombinant human tumor necrosis factor-alpha reciprocally regulate the generation of lymphokine-activated killer cell activity. Comparison between natural porcine platelet-derived TGF-beta 1 and TGF-beta 2, and recombinant human TGF-beta 1.